Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Calorie restriction extends lifespan and produces a metabolic profile desirable for treating diseases of ageing such as type 2 diabetes. SIRT1, an NAD+-dependent deacetylase, is a principal modulator of pathways downstream of calorie restriction that produce beneficial effects on glucose homeostasis and insulin sensitivity. Resveratrol, a polyphenolic SIRT1 activator, mimics the anti-ageing effects of calorie restriction in lower organisms and in mice fed a high-fat diet ameliorates insulin resistance, increases mitochondrial content, and prolongs survival. Here we describe the identification and characterization of small molecule activators of SIRT1 that are structurally unrelated to, and 1,000-fold more potent than, resveratrol. These compounds bind to the SIRT1 enzyme-peptide substrate complex at an allosteric site amino-terminal to the catalytic domain and lower the Michaelis constant for acetylated substrates. In diet-induced obese and genetically obese mice, these compounds improve insulin sensitivity, lower plasma glucose, and increase mitochondrial capacity. In Zucker fa/fa rats, hyperinsulinaemic-euglycaemic clamp studies demonstrate that SIRT1 activators improve whole-body glucose homeostasis and insulin sensitivity in adipose tissue, skeletal muscle and liver. Thus, SIRT1 activation is a promising new therapeutic approach for treating diseases of ageing such as type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, we show that recently developed SIRT1 activators, which are effective in improving energy homeostasis and decreasing hepatosteatosis in mouse models (Milne et al. 2007;Feige et al. 2008), also increase ubiquitination and proteasomal targeting of SREBP-1a, resulting in decreased SREBP-1 nuclear levels and target gene expression.”
From Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP (2010) · cites this paper as Milne et al. 2007
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent studies have reported the identification of potent SIRT1-activating compounds, and showed that such SIRT1 activators could significantly ameliorate insulin resistance and improve energy homeostasis in mouse diet-induced obesity models (Milne et al. 2007).”
From Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP (2010) · cites this paper as Milne et al. 2007
In the citing paper
“In contrast to these negative regulators of insulin action, SIRT1 appears to be a positive regulator of insulin sensitivity (43,44).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [43]
In the citing paper
“Additionally, the non-naturally occurring sirtuin-activating compound, SRT1720, has enhanced insulin sensitivity and oxidative metabolism in animal models of obesity, in part, by improving mitochondrial oxidative capacity231.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [231]
In the citing paper
“Other related small molecules are more potent than resveratrol to enhance the action of SIRT1 on substrates for deacetylation (218). These compounds also improve insulin sensitivity in obese rodents (218).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [218]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Self-citationLagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Self-citationSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Self-citationTranscriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924
Self-citationSirtuin activators mimic caloric restriction and delay ageing in metazoans
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868
Self-citation
Research works printed but not linked: 1
- Banks A, et al. Overexpression of the Sirtuin SIRT1 increases insulin sensitivity in aging mice. Diabetes. 2007;56(S1):0234-OR. [Google Scholar]
Cited by
Items 401–500 of 1,004
Chemical and structural biology of protein lysine deacetylases
Yoshida, M., Kudo, N., Kosono, S., & Ito, A. (2017) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.93.019 · Cited by 115
Sirtuin-1 (SIRT1) Is Required for Promoting Chondrogenic Differentiation of Mesenchymal Stem Cells
Buhrmann, C., Busch, F., Shayan, P., & Shakibaei, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568790 · Cited by 109
“One of the most important and functional novel molecular targets of resveratrol is sirtuin-1 (SIRT1), a member of the sirtuin family of nicotinamide adenine dinucleotide (NAD)-dependent deacetylases, which is found to be an anti-aging gene (25, 26).”
BackgroundImidazothiazole and related heterocyclic systems. Synthesis, chemical and biological properties
Fascio, M. L., Errea, M. I., & D’Accorso, N. B. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.12.012 · Cited by 102
Can yeast systems biology contribute to the understanding of human disease?
Petranović, D., & Nielsen, J. (2008) · Trends in biotechnology · doi:10.1016/j.tibtech.2008.07.008 · Cited by 131
Breitenstein, A., Stein, S., Holy, E. W., Camici, G. G., Lohmann, C., Akhmedov, A., Spescha, R., Elliott, P. J., Westphal, C. H., Matter, C. M., et al. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq339 · Cited by 102
Self-citationThe Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stress
Ren, Y., Du, C., Shi, Y., Wei, J., Wu, H., & Cui, H. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.2931 · Cited by 100
“…this study, we investigated the effects of the Sirt1 activator, SRT1720, a small molecule activator of Sirt1 that is more potent than resveratrol (11), on UUO-induced renal tubulointerstitial fibrosis and we aimed to determine whether these effects are mediated by the inhibition of oxidative…”
Park, S., Kim, M. Y., Baik, S. H., Woo, J.-T., Kwon, Y. J., Daily, J. W., Park, Y.-M., Jh, Y., & Kim, S.-H. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.207 · Cited by 116
Adipocyte SIRT 1 controls systemic insulin sensitivity by modulating macrophages in adipose tissue
Hui, X., Zhang, M., Gu, P., Li, K., Gao, Y., Wu, D., Wang, Y., & Xu, A. (2017) · EMBO reports · doi:10.15252/embr.201643184 · Cited by 100
Cunningham, K. E., Vincent, G., Sodhi, C. P., Novak, E. A., Ranganathan, S., Egan, C. E., Stolz, D. B., Rogers, M. B., Firek, B., Morowitz, M. J., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.688812 · Cited by 107
Mitochondrial metabolism and diabetes
Kwak, S. H., Park, K. S., Lee, K., & Lee, H. K. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00047.x · Cited by 112
Metabolic benefits from Sirt1 and Sirt1 activators
Chaudhary, N., & Pfluger, P. T. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32832cdaae · Cited by 108
Sun, J., He, X., Zhu, Y., Ding, Z., Dong, H., Feng, Y., Du, J., Wang, H., Wu, X., Zhang, L., et al. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.07.018 · Cited by 103
“Our results suggest that the SIRT1 agonist SRT1720 (Milne et al., 2007), which directly interacts with and activates SIRT1 through an allosteric mechanism (Hubbard et al.”
Park, S., Shin, J., Bae, J., Han, D., Park, S., Shin, J., Lee, S. K., & Park, H. (2020) · Cells · doi:10.3390/cells9030728 · Cited by 104
Yu, J., Wu, Y., & Yang, P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13587 · Cited by 100
Negative reciprocal regulation between Sirt1 and Per2 modulates the circadian clock and aging
Wang, R.-H., Zhao, T., Cui, K., Hu, G., Chen, Q., Chen, W., Wang, X.-W., Soto-Gutierrez, A., Zhao, K., & Deng, C.-X. (2016) · Scientific Reports · doi:10.1038/srep28633 · Cited by 98
“In mice, whole-body Sirt1 overexpression 37 or activation of Sirt1 by SRT1720 38 did not increase lifespan, although it did improve metabolic conditions.”
SIRT1 Antagonizes Oxidative Stress in Diabetic Vascular Complication
Meng, T., Qin, W., & Liu, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.568861 · Cited by 108
“There are several other SIRT1 activators, such as SRT1720 (an analogue of resveratrol), that have been shown to enhance SIRT1 activity in mammals (36, 124).”
BackgroundResveratrol and red wine, healthy heart and longevity
Das, D. K., Mukherjee, S., & Ray, D. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9163-9 · Cited by 113
“Evidence is available to show the positive effects of resveratrol and SIRT1 activation on several age-related disorders including type-2 diabetes, cardiovascular disease, neuro-degeneration and inflammation [10, 61, 72, 73].”
BackgroundSIRT1/SREBPs-mediated regulation of lipid metabolism
Shen, S., Shen, M., Kuang, L., Yang, K., Wu, S., Liu, X., Wang, Y., & Wang, Y. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.107037 · Cited by 115
Fuentes‐Antrás, J., Ioan, A.-M., Tuñón, J., Egido, J., & Lorenzo, Ó. (2014) · International Journal of Endocrinology · doi:10.1155/2014/847827 · Cited by 103
“ZDF rats undergoing this treatment effectively improved whole-body glucose homeostasis and insulin resistance [124].”
BackgroundAltered mitochondrial metabolism in the insulin‐resistant heart
Makrecka‐Kuka, M., Liepinsh, E., Murray, A. J., Lemieux, H., Dambrova, M., Tepp, K., Puurand, M., Käämbre, T., Han, W. H., de Goede, P., et al. (2019) · Acta Physiologica · doi:10.1111/apha.13430 · Cited by 102
Gabandé‐Rodríguez, E., Heras, M. M. G. D. L., & Mittelbrunn, M. (2019) · Cells · doi:10.3390/cells9010082 · Cited by 106
Molecular Basis of the Beneficial Actions of Resveratrol
Repossi, G., Das, U. N., & Eynard, A. R. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.01.010 · Cited by 105
The role of sirtuins in modulating redox stressors
Webster, B. R., Lu, Z., Sack, M. N., & Scott, I. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.484 · Cited by 96
“The potential role of SIRT1 in a number of vital physiological pathways has made it a prime target for pharmacological intervention (see [13,14]).”
BackgroundInhibition of transcriptional activity of c-JUN by SIRT1
Gao, Z., & Ye, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.079 · Cited by 96
“SIRT1 (Sirtuin 1) referred as Sir2 (silencing information regulator 2) in yeast, is a nicotinamide adenine dinucleotide (NAD)–dependent histone deacetylase, which is implicated in the regulation of many cellular processes, including apoptosis, cellular senescence, aging, longevity and glucose homeostasis [7–9].”
BackgroundAssociation of SIRT1 gene variation with visceral obesity
Peeters, A. V., Beckers, S., Verrijken, A., Mertens, I. L., Roevens, P. W. M., Peeters, P. J., Hul, W. V., & Gaal, L. F. V. (2008) · Human Genetics · doi:10.1007/s00439-008-0567-8 · Cited by 107
“Genomic DNA was extracted from whole blood by a method adapted from Miller et al. (1988) .”
BackgroundMethodMercader, J., Palou, A., & Bonet, M. L. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.07.007 · Cited by 107
“Effects of resveratrol on energy metabolism and metabolic health are most likely SIRT1-mediated, as similar changes have been described in transgenic mice overexpressing SIRT1 [7,8] and in rodents treated with synthetic SIRT1 activators [9–11], and they have been linked to the ability of SIRT1 to deacetylate and there…”
BackgroundVassallo, P. F., Simoncini, S., Ligi, I., Chateau, A.-L., Bachelier, R., Robert, S., Morere, J., Fernandez, S., Guillet, B., Marcelli, M., et al. (2014) · Blood · doi:10.1182/blood-2013-02-484956 · Cited by 94
“50,51 45-48 Together with RSV, small-molecule activators of SIRT1 have been proposed in the treatment of type 2 diabetes, 52,53 another disease associatedwithPT.”
BackgroundSathishkumar, C., Prabu, P., Balakumar, M., Lenin, R., Prabhu, D., Anjana, R. M., Mohan, V., & Balasubramanyam, M. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0293-3 · Cited by 93
“On the other hand, sirtuin1 (Sirt1, a class III HDAC) which is a well-known metabolic regulator of glucose homeostasis and insulin resistance-associated inflammation is reduced in diabetes, and enhanced activity of sirt1 has been shown to be protective against diabetes [15].”
BackgroundBugyei‐Twum, A., Ford, C., Civitarese, R., Seegobin, J., Advani, S. L., Desjardins, J., Kabir, G., Zhang, Y., Mitchell, M., Switzer, J., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy131 · Cited by 102
Wang, C.-H., & Wei, Y.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155266 · Cited by 95
Zhou, Z., Fan, Y., Zong, R., & Tan, K. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101702 · Cited by 104
Redox Regulation of Sirtuin-1 by S -Glutathiolation
Zee, R. S., Yoo, C. B., Pimentel, D. R., Perlman, D. H., Burgoyne, J. R., Hou, X., McComb, M. E., Costello, C. E., Cohen, R. A., & Bachschmid, M. M. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3251 · Cited by 95
“At present, potent small molecule activators of SIRT1 are highly sought after for their therapeutic potential (15).”
Yi, Y. W., Kang, H. J., Kim, H. J., Kong, Y., Brown, M. L., & Bae, I. (2013) · Oncotarget · doi:10.18632/oncotarget.1070 · Cited by 94
“Although several SIRT1 activating compounds have been recently developed [20-23], the anti-cancer effects of these compounds have not been reported.”
BackgroundAMP-activated protein kinase as a key molecular link between metabolism and clockwork
Lee, Y., & Kim, E.-K. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.65 · Cited by 93
Hasselgren, P.-O., Alamdari, N., Aversa, Z., Gonnella, P., Smith, I. J., & Tizio, S. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833a5107 · Cited by 94
Resveratrol Inhibits Pathologic Retinal Neovascularization in Vldlr−/−Mice
Hua, J., Guerin, K. I., Chen, J., Michán, S., Stahl, A., Krah, N. M., Seaward, M. R., Dennison, R. J., Juan, A. M., Hatton, C. J., et al. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6496 · Cited by 94
Self-citationAdiponectin, an Unlocking Adipocytokine
Sun, Y., Xun, K., Wang, C., Zhao, H., Bi, H., Chen, X., & Wang, Y. (2009) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2008.00069.x · Cited by 94
“Sirt1, a NAD/-dependent deacetylase, is a principal modulator of pathways downstream of calorie restriction that produces beneficial effects on glucose homeostasis and insulin sensitivity [146].”
BackgroundGurd, B. J., Yoshida, Y., McFarlan, J. T., Holloway, G. P., Moyes, C. D., Heigenhauser, G. J. F., Spriet, L., & Bonen, A. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00417.2010 · Cited by 94
Constitutive SIRT1 overexpression impairs mitochondria and reduces cardiac function in mice
Kawashima, T., Inuzuka, Y., Okuda, J., Kato, T., Niizuma, S., Tamaki, Y., Iwanaga, Y., Kawamoto, A., Narazaki, M., Matsuda, T., et al. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.09.013 · Cited by 101
“SIRT1 and resveratrol protected mice from neurodegenerative diseases [59].”
BackgroundBaksi, A., Kraydashenko, O., Zalevkaya, A., Stets, R., Elliott, P., Haddad, J., Hoffmann, E., Vlasuk, G. P., & Jacobson, E. W. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12327 · Cited by 90
Self-citationA chemical probe toolbox for dissecting the cancer epigenome
Shortt, J., Ott, C. J., Johnstone, R. W., & Bradner, J. E. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2016.148 · Cited by 98
Wierzbiński, K. R., Szymański, T., Rozwadowska, N., Rybka, J. D., Zimna, A., Zalewski, T., Nowicka-Bauer, K., Malcher, A., Nowaczyk, M., Krupiński, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22018-0 · Cited by 97
Kratz, E. M., Sołkiewicz, K., Kubis-Kubiak, A., & Piwowar, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020630 · Cited by 105
Role of CoA and acetyl-CoA in regulating cardiac fatty acid and glucose oxidation
Alrob, O. A., & Lopaschuk, G. D. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140094 · Cited by 103
Resveratrol and rapamycin: are they anti‐aging drugs?
Kaeberlein, M. (2010) · BioEssays · doi:10.1002/bies.200900171 · Cited by 92
“With respect to obesity, additional sirtuin activators have also shown similar protection inmice,((16)) suggesting that this effect of resveratrol is likely mediated by sirtuins, although not necessarily through a direct activation.”
BackgroundGurd, B. J., Yoshida, Y., Lally, J., Holloway, G. P., & Bonen, A. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.168096 · Cited by 91
Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators
Bemis, J. E., Vu, C. B., Xie, R. L., Nunes, J. J., Ng, P. Y., Disch, J. S., Milne, J. C., Carney, D. P., Lynch, A. V., Jin, L., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.11.106 · Cited by 95
Self-citationErythropoietin, a Novel Versatile Player Regulating Energy Metabolism beyond the Erythroid System
Wang, L., Di, L., & Noguchi, C. T. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.9518 · Cited by 95
“Activating Sirt1 in mice contributes to protection against high-fat-induced obesity and metabolic disorders [162-164].”
BackgroundHammer, S. S., Vieira, C. P., McFarland, D., Sandler, M., Levitsky, Y., Dorweiler, T. F., Lydic, T. A., Asare‐Bediako, B., Adu-Agyeiwaah, Y., Sielski, M. S., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05431-5 · Cited by 105
“Activation of SIRT1, via SRT1720, has been shown to significantly improve insulin sensitivity, lower glucose levels and increase mitochondrial and metabolic function [62].”
BackgroundRibosomal Protein S6: A Potential Therapeutic Target against Cancer?
Yi, Y. W., You, K. S., Park, J., Lee, S., & Seong, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010048 · Cited by 111
“SRT2183 3 a SIRT1 activator [311] 3 reduces p-RPS6 (S240/244), p-AKT (S473), p-mTOR (S2448), and p-p70S6K (T389) in ovarian cancer OVCAR-3 and A2780 cells”
Intercellular interplay between Sirt1 signalling and cell metabolism in immune cell biology
Chen, X., Lu, Y., Zhang, Z., Wang, J., Yang, H., & Liu, G. (2015) · Immunology · doi:10.1111/imm.12473 · Cited by 97
Self-citationBauerly, K. A., Harris, C., Chowanadisai, W., Graham, J. L., Havel, P. J., Tchaparian, E. H., Satre, M. A., Karliner, J. S., & Rucker, R. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021779 · Cited by 91
“[38] have described novel activators of SIRT1, whose administration to insulin-resistant animals improves glucose homeostasis.”
BackgroundLi, P., Zhao, Y., Wu, X., Xia, M., Fang, M., Iwasaki, Y., Sha, J., Chen, Q., Xu, Y., & Shen, A. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr984 · Cited by 91
“Despite these observations and the fact that SIRT1 agonists show potential in the treatment of type 2 diabetes (16), it remains undetermined the exact mechanism whereby SIRT1 expression is regulated.”
BackgroundSirtuin 1 in immune regulation and autoimmunity
Kong, S., McBurney, M. W., & Fang, D. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.102 · Cited by 100
NAD+-dependent histone deacetylases (sirtuins) as novel therapeutic targets
Schemies, J., Uciechowska, U., Sippl, W., & Jung, M. (2009) · Medicinal Research Reviews · doi:10.1002/med.20178 · Cited by 107
“They improved insulin sensitivity in a mouse model of diabetes type 2.(126) N H”
BackgroundApurinic/apyrimidinic endonuclease 1 is a key modulator of aluminum-induced neuroinflammation
Zaky, A., Mohammad, B., Moftah, M. Z., Kandeel, K., & Bassiouny, A. R. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-26 · Cited by 94
Asaka, R., Miyamoto, T., Yamada, Y., Ando, H., Mvunta, D. H., Kobara, H., & Shiozawa, T. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.119 · Cited by 96
Imai, S.-I. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.01.006 · Cited by 89
Wuertz‐Kozak, K., Quero, L., Sekiguchi, M., Klawitter, M., Nerlich, M. L., Konno, S., Kikuchi, S., & Boos, N. (2011) · Spine · doi:10.1097/brs.0b013e318221e655 · Cited by 97
SIRT1: roles in aging and cancer
Kim, E.-J., & Um, S.-J. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.11.751 · Cited by 88
Metabolic and Neuropsychiatric Effects of Calorie Restriction and Sirtuins
Libert, S., & Guarente, L. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183800 · Cited by 89
“Private companies such as Sirtris Pharmaceuticals (which has been acquired by GlaxoSmithKline) identified many of the synthetic compounds that activate SIRT1 (69), some of which are in clinical trials (see http://ClinicalTrials.”
BackgroundSirtuins and the circadian clock: Bridging chromatin and metabolism
Masri, S., & Sassone-Corsi, P. (2014) · Science Signaling · doi:10.1126/scisignal.2005685 · Cited by 88
Bagetta, D., Maruca, A., Lupia, A., Mesiti, F., Catalano, R., Romeo, I., Moraca, F., Ambrosio, F. A., Costa, G., Artese, A., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111903 · Cited by 88
Ultrasound for Drug Synthesis: A Green Approach
Draye, M., Châtel, G., & Duwald, R. (2020) · Pharmaceuticals · doi:10.3390/ph13020023 · Cited by 93
Broussy, S., Laaroussi, H., & Vidal, M. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1758691 · Cited by 98
Mitochondrial oxidative injury: a key player in nonalcoholic fatty liver disease
Dornas, W., & Schuppan, D. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00121.2020 · Cited by 97
“Mitochondrial energy output was enhanced in patients through activation of Sirt1 by use of polyphenols, such as resveratrol or its analogs, and upregulation of PGC-1 and PGC-1 stimulated mitochondrial OXPHOS in cells harboring mtDNA mutations, demonstrating therapeutic benefit of certain polyphenols for disorders of m…”
BackgroundSirtuins in atherosclerosis: guardians of healthspan and therapeutic targets
Grootaert, M. O. J., & Bennett, M. R. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00685-x · Cited by 94
Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin‐induced mouse model of asthma
Ichikawa, T., Hayashi, R., Suzuki, K., Imanishi, S., Kambara, K., Okazawa, S., Inomata, M., YAMADA, T., YAMAZAKI, Y., Koshimizu, Y., et al. (2013) · Respirology · doi:10.1111/j.1440-1843.2012.02284.x · Cited by 96
Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type‐2 diabetes
Sharma, S., Misra, C. S., Arumugam, S., Roy, S., Shah, V., Davis, J. A., Shirumalla, R. K., & Ray, A. (2010) · Phytotherapy Research · doi:10.1002/ptr.3221 · Cited by 102
“However, early results of resveratrol with higher doses were also unable to signifi cantly improve these parameters suggesting that longer duration of treatment helps improve such parameters (Milne et al., 2007).”
BackgroundPurushotham, A., Xu, Q., Lu, J., Foley, J. F., Yan, X., Kim, D.-H., Kemper, J. K., & Li, X. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05988-11 · Cited by 87
“In addition, activation of SIRT1 by its activators in animals protects against high-fat-induced obesity and insulin resistance (4, 23, 30), and modest overexpression of SIRT1 resulted in a protective effect against highfat-induced hepatic steatosis and glucose intolerance (3, 37).”
BackgroundWan, X., Wen, J.-J., Koo, S.-J., Liang, L. Y., & Garg, N. J. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005954 · Cited by 99
SIRT1 Modulators in Experimentally Induced Liver Injury
Farghali, H., Kemelo, M. K., & Canová, N. K. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8765954 · Cited by 88
“They are up to 1000-fold more potent for SIRT1 than resveratrol [75].”
BackgroundElesela, S., Morris, S. B., Narayanan, S., Kumar, S., Lombard, D. B., & Lukacs, N. W. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008319 · Cited by 98
“SIRT1 is involved in various physiological processes including aging, energy metabolism, and stress responses [39] and therefore has been considered a potential therapeutic target for multiple diseases like cancer, Alzheimer’s, diabetes, and atherosclerosis [40, 41].”
BackgroundIntersection between metabolic dysfunction, high fat diet consumption, and brain aging
Uranga, R. M., Bruce‐Keller, A. J., Morrison, C. D., Fernandez‐Kim, S. O., Ebenezer, P. J., Zhang, L., Dasuri, K., & Keller, J. N. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06803.x · Cited by 87
“Sirt1 activators have been found to be beneficial for mitochondrial and metabolic function in obese rodents and are currently being studied as potential treatments for type-2 diabetes (Milne et al. 2007).”
BackgroundThiosuccinyl Peptides as Sirt5-Specific Inhibitors
He, B., Du, J., & Lin, H. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2090417 · Cited by 85
SIRTUIN 1: Regulating the regulator
Zschoernig, B., & Mahlknecht, U. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.137 · Cited by 99
Recent and emerging anti‐diabetes targets
Mohler, M. L., He, Y., Wu, Z., Hwang, D., & Miller, D. D. (2008) · Medicinal Research Reviews · doi:10.1002/med.20142 · Cited by 93
Allard, J. S., Perez, E., Zou, S., & de Cabo, R. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.018 · Cited by 95
Rajendrasozhan, S., Yao, H., & Rahman, I. (2009) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550903049132 · Cited by 91
“SIRT1 plays a key role in regulation of NF-κB-dependent pro-inflammatory cytokines release as shown by pharmacological, and genetic loss and gain approaches (10, 23, 24, 42, 44, 45).”
BackgroundChoudhury, G., & MacNee, W. (2016) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2016.1214948 · Cited by 101
“Recently, a new SIRT1-specific activator SRT2172 has been described (161).”
BackgroundInduction of mitochondrial biogenesis protects against acetaminophen hepatotoxicity
Du, K., Ramachandran, A., McGill, M. R., Mansouri, A., Asselah, T., Farhood, A. I., Woolbright, B. L., Ding, W., & Jaeschke, H. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.08.020 · Cited by 93
“SRT1720 is a derivative of the natural product resveratrol that is thought to be a potent activator of Sirt1 and Pgc-1α (Milne et al., 2007; Cameron et al., 2016), although it has been suggested that it may act on Sirt1 indirectly or even have off-target effects that lead to MB (Pacholec et al.,…”
BackgroundMethodTargeting SIRT1 Rescues Age- and Obesity-Induced Microvascular Dysfunction in Ex Vivo Human Vessels
Mengozzi, A., Costantino, S., Paneni, F., Duranti, E., Nannipieri, M., Mancini, R., Lai, M., Rocca, V. L., Puxeddu, I., Antonioli, L., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.320888 · Cited by 95
Baba, R., Hori, Y., Mizukami, S., & Kikuchi, K. (2012) · Journal of the American Chemical Society · doi:10.1021/ja306045j · Cited by 88
Epigenetic drug discovery for Alzheimer’s disease
Cacabelos, R., & Torrellas, C. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.930124 · Cited by 96
Small molecules from natural sources, targeting signaling pathways in diabetes
Liu, Q., Chen, L., Hu, L., Guo, Y., & Shen, X. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.06.004 · Cited by 98
Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus
So, W. Y., & Leung, P. S. (2016) · Medicinal Research Reviews · doi:10.1002/med.21390 · Cited by 93
“The engineered FGF21, FGF21(1-171)-WD22, is functionally indistinguishable from native FGF21 in terms of signaling activation, receptor binding specificity, and induction of adipose glucose uptake, but has increased potency with the more tolerant C-terminal modification.”
BackgroundResveratrol and the eye: activity and molecular mechanisms
Bola, C., Bartlett, H. E., & Eperjesi, F. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2604-8 · Cited by 94
Moniot, S., Weyand, M., & Steegborn, C. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00016 · Cited by 96
“Sirtuin activating compounds, initially resveratrol-related polyphenols (Figure 1B) and subsequently other compound classes (Howitz et al., 2003; Milne et al., 2007), can promote survival of human cells, extend lifespan in various species, and protect against insulin resistance (Guarente and…”
BackgroundNADPH oxidases 1 and 4 mediate cellular senescence induced by resveratrol in human endothelial cells
Schilder, Y. D. C., Heiß, E. H., Schachner, D., Ziegler, J., Reznicek, G., Sorescu, D., & Dirsch, V. M. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.03.013 · Cited by 96
“Resveratrol aswell as SIRT1was also described as an insulin sensitizer [11,41,42].”
BackgroundCsiszár, A., Csiszar, A., Pinto, J. T., Gautam, T., Kleusch, C., Hoffmann, B., Tucsek, Z., Toth, P., Sonntag, W. E., & Ungvari, Z. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu029 · Cited by 85
Resveratrol-Induced Sirt1 Activation Derives from Sirt1 Phosphorylation by LKB1
Huang, Y., Lu, J., Li, Z., Wang, M., Shi, R., Yuan, X. N., Gao, X., Liu, X., Zang, J., Liu, W., et al. (2020) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100929 · Cited by 89
“Consistent with the effect of resveratrol, treatment of cells with another Sirt1 activator SRT1720 also upregulated the interaction between LKB1 and Sirt1 (Fig.”
MethodManna, P., & Jain, S. K. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373949 · Cited by 94
Role of Sirtuin 1 in the Regulation of Hepatic Gene Expression by Thyroid Hormone
Thakran, S., Sharma, P., Attia, R. R., Hori, R. T., Deng, X., Elam, M. B., & Park, E. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437970 · Cited by 84
“Resveratrol also has positive hepatic actions including the enhancement of mitochondrial metabolism and the reduction of hepatic steatosis (55).”
BackgroundMethodInhibition of SUV39H1 Methyltransferase Activity by DBC1
Li, Z., Chen, L., Kabra, N., Wang, C., Fang, J., & Chen, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900956200 · Cited by 89
The proteostasis boundary in misfolding diseases of membrane traffic
Hutt, D. M., Powers, E. T., & Balch, W. E. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.07.014 · Cited by 84
“Strikingly, global modulators of the FRS, including the histone deacetylase inhibitors (HDACi) including 4-PBA [72,73] and activators of sirtuins [74–77] were found to attenuate the FRS response and restore β-cell homeostasis.”
BackgroundBo, S., Togliatto, G., Gambino, R., Ponzo, V., Lombardo, G., Rosato, R., Cassader, M., & Brizzi, M. F. (2018) · Acta Diabetologica · doi:10.1007/s00592-017-1097-4 · Cited by 89
“One sirtuin family member, SIRT-1, was found persistently downregulated in T2DM patients [6] and has been associated with mitochondrial ROS accumulation and increased p53 acetylation (p53ac) levels [7, 8].”
BackgroundDiabetes mellitus: new challenges and innovative therapies
Sena, C. M., Bento, C. F., Pereira, P., & Seiça, R. M. F. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0010-9 · Cited by 105
Kim, J., Jo, J., Kim, K., An, H., Gwon, M., Gu, H., Kim, H.-J., Yang, A. Y., Kim, S.-W., Jeon, E. J., et al. (2019) · Antioxidants · doi:10.3390/antiox8080322 · Cited by 87
“SRT1720 is a small molecule that potently and specifically activates Sirt1 [11].”
BackgroundAging and Inflammation: Etiological Culprits of Cancer
Ahmad, A., Banerjee, S., Wang, Z. P., Kong, D., Majumdar, A. P. N., & Sarkar, F. H. (2009) · Current Aging Science · doi:10.2174/1874609810902030174 · Cited by 87
“A few other agents with SIRT1 modulating activity have since been identified [95].”
BackgroundKidney aging—inevitable or preventable?
Choudhury, D., & Levi, M. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.104 · Cited by 89
Metadata
- Authors
- Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., Bemis, J. E., Xie, R., Disch, J. S., Ng, P. Y., Nunes, J. J., Lynch, A. V., Yang, H., Galonek, H., Israelian, K., Choy, W., Iffland, A., Lavu, S., Medvedik, O., Sinclair, D. A., Olefsky, J. M., Jirousek, M. R., Elliott, P. J., & Westphal, C. H.
- Affiliations
- University of California San Diego (US)
- Harvard University (US)
- Corresponding author
- Westphal, Christoph H.
- ORCID
- Venue
- Nature
- Published
- 2007-11-29
- Volume
- 450
- Issue
- 7170
- Pages
- 712-716
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2753457
- OpenAlex
- W2116350182
- Cited by
- 1,707
- References
- 27
- Citations by year
- 2026: 38 · 2025: 43 · 2024: 55 · 2023: 55 · 2022: 68 · 2021: 100 · 2020: 80 · 2019: 75 · 2018: 82 · 2017: 69 · 2016: 92 · 2015: 89 · 2014: 110 · 2013: 119 · 2012: 126
- FWCI
- 55.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute on Aging (P01AG027916, R01AG028730, R01AG019719)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- SIRT1, small molecule activators, type 2 diabetes, insulin resistance, caloric restriction mimetics, resveratrol, NAD+-dependent deacetylase, allosteric site, glucose homeostasis, mitochondrial function, obesity, aging, drug screening
- MeSH terms
- Resveratrol, Acetylation, Allosteric Site, Animals, Blood Glucose, Cell Line, Diabetes Mellitus, Type 2, Dietary Fats, Disease Models, Animal, Drosophila melanogaster, Heterocyclic Compounds, 4 or More Rings, Humans, Insulin, Male, Mitochondria, Rats, Zucker, Stilbenes, Rats, Sprague-Dawley, Catalytic Domain, Caloric Restriction, Sirtuins, Mice, Rats, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.